Statistics for Development of MEPS–UHPLC/PDA methodology for the quantification of clozapine, risperidone and their major active metabolites in human urine
Total visits
| views | |
|---|---|
| Development of MEPS–UHPLC/PDA methodology for the quantification of clozapine, risperidone and their major active metabolites in human urine | 68 |
Total visits per month
| views | |
|---|---|
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
Top country views
| views | |
|---|---|
| United States | 38 |
| China | 8 |
| Portugal | 7 |
| United Kingdom | 5 |
| Brazil | 2 |
| Canada | 2 |
| Australia | 1 |
| Germany | 1 |
| Malaysia | 1 |
| Serbia | 1 |
| Thailand | 1 |